anurajms/meta_analysis huggingface dataset:
MESH terms:
Cuffed versus uncuffed endotracheal tubes for general anaesthesia in children aged eight years and under
1. *Equipment Design; 2. Adrenal Cortex Hormones [therapeutic use]; 3. Anesthesia, General [*instrumentation]; 4. Bronchodilator Agents [therapeutic use]; 5. Epinephrine [therapeutic use]; 6. Intensive Care Units, Neonatal [statistics & numerical data]; 7. Intubation, Intratracheal [adverse effects, economics, *instrumentation]; 8. Randomized Controlled Trials as Topic; 9. Respiratory Sounds [etiology];
MESH terms:
Dexamethasone as an adjuvant to peripheral nerve block
1. Anesthetics, Local [*administration & dosage]; 2. Arm [surgery]; 3. Dexamethasone [*administration & dosage]; 4. Glucocorticoids [*administration & dosage]; 5. Injections, Intravenous; 6. Leg [surgery]; 7. Nerve Block [adverse effects, *methods]; 8. Neuromuscular Blocking Agents [*administration & dosage]; 9. Pain, Postoperative [*prevention & control]; 10. Randomized Controlled Trials as Topic; 11. Time Factors;
MESH terms:
Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults
1. Analgesia [methods]; 2. Arthroplasty, Replacement, Hip [*adverse effects]; 3. Confusion [etiology]; 4. Length of Stay; 5. Nerve Block [adverse effects, *methods]; 6. Pain Management [*methods]; 7. Pain, Postoperative [*prevention & control]; 8. Pruritus [etiology]; 9. Randomized Controlled Trials as Topic;
MESH terms:
Heat and moisture exchangers versus heated humidifiers for mechanically ventilated adults and children
1. *Humidity; 2. *Respiration, Artificial [adverse effects]; 3. *Steam; 4. Cross‐Over Studies; 5. Heating [*instrumentation]; 6. Pneumonia [etiology]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Harms of off‐label erythropoiesis‐stimulating agents for critically ill people
1. Anemia [blood, *drug therapy, mortality]; 2. Biosimilar Pharmaceuticals [adverse effects]; 3. *Critical Illness; 4. Erythropoiesis [*drug effects]; 5. Hematinics [*adverse effects]; 6. Observational Studies as Topic; 7. *Off-Label Use; 8. Randomized Controlled Trials as Topic; 9. Venous Thromboembolism [chemically induced];
MESH terms:
Interventions for treating persistent pain in survivors of torture
1. *Survivors; 2. *Torture; 3. *Waiting Lists; 4. Biofeedback, Psychology [*methods]; 5. Chronic Pain [etiology, *therapy]; 6. Cognitive Behavioral Therapy [*methods]; 7. Low Back Pain [*therapy]; 8. Musculoskeletal Manipulations [*methods]; 9. Patient Dropouts [statistics & numerical data]; 10. Randomized Controlled Trials as Topic [ethics]; 11. Self Care [*methods]; 12. Stress, Psychological [therapy];
MESH terms:
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults
1. *Neuromuscular Blockade; 2. Androstanols [antagonists & inhibitors]; 3. Atracurium [analogs & derivatives, antagonists & inhibitors]; 4. Cholinesterase Inhibitors [administration & dosage, adverse effects, *pharmacology]; 5. Neostigmine [administration & dosage, adverse effects, *pharmacology]; 6. Neuromuscular Nondepolarizing Agents [*antagonists & inhibitors]; 7. Randomized Controlled Trials as Topic; 8. Rocuronium; 9. Sugammadex; 10. Time Factors; 11. Vecuronium Bromide [antagonists & inhibitors]; 12. gamma‐Cyclodextrins [administration & dosage, adverse effects, *pharmacology];
MESH terms:
Antidepressants for chronic non‐cancer pain in children and adolescents
1. Abdominal Pain [*drug therapy]; 2. Amines [adverse effects, therapeutic use]; 3. Amitriptyline [adverse effects, therapeutic use]; 4. Analgesics [adverse effects, *therapeutic use]; 5. Antidepressive Agents [adverse effects, *therapeutic use]; 6. Chronic Pain [*drug therapy]; 7. Citalopram [adverse effects, therapeutic use]; 8. Complex Regional Pain Syndromes [*drug therapy]; 9. Cyclohexanecarboxylic Acids [adverse effects, therapeutic use]; 10. Dyspepsia [*drug therapy]; 11. Gabapentin; 12. Irritable Bowel Syndrome [*drug therapy]; 13. Neuralgia [*drug therapy]; 14. Placebos [therapeutic use]; 15. Randomized Controlled Trials as Topic; 16. gamma‐Aminobutyric Acid [adverse effects, therapeutic use];
MESH terms:
Antiepileptic drugs for chronic non‐cancer pain in children and adolescents
1. Amines [adverse effects, *therapeutic use]; 2. Amitriptyline [adverse effects, *therapeutic use]; 3. Anticonvulsants [adverse effects, *therapeutic use]; 4. Chronic Pain [*drug therapy]; 5. Complex Regional Pain Syndromes [*drug therapy]; 6. Cyclohexanecarboxylic Acids [adverse effects, *therapeutic use]; 7. Fibromyalgia [*drug therapy]; 8. Gabapentin; 9. Neuralgia [*drug therapy]; 10. Pregabalin [adverse effects, *therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. gamma‐Aminobutyric Acid [adverse effects, *therapeutic use];
MESH terms:
Non‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents
1. Anti-Inflammatory Agents, Non-Steroidal [adverse effects, *therapeutic use]; 2. Arthritis, Juvenile [*drug therapy]; 3. Arthritis, Rheumatoid [*drug therapy]; 4. Aspirin [adverse effects, therapeutic use]; 5. Celecoxib [adverse effects, therapeutic use]; 6. Chronic Disease; 7. Chronic Pain [*drug therapy]; 8. Fenoprofen [adverse effects, therapeutic use]; 9. Ibuprofen [adverse effects, therapeutic use]; 10. Lactones [adverse effects, therapeutic use]; 11. Meloxicam; 12. Methoxsalen [adverse effects, therapeutic use]; 13. Naproxen [adverse effects, therapeutic use]; 14. Randomized Controlled Trials as Topic; 15. Sulfones [adverse effects, therapeutic use]; 16. Thiazines [adverse effects, therapeutic use]; 17. Thiazoles [adverse effects, therapeutic use];
MESH terms:
Paracetamol (acetaminophen) for chronic non‐cancer pain in children and adolescents
1. Acetaminophen [*therapeutic use]; 2. Analgesics, Non‐Narcotic [*therapeutic use]; 3. Chronic Pain [*drug therapy];
MESH terms:
Opioids for chronic non‐cancer pain in children and adolescents
1. Analgesics, Opioid [adverse effects, *therapeutic use]; 2. Chronic Pain [*drug therapy, etiology];
MESH terms:
Videolaryngoscopy versus direct laryngoscopy for tracheal intubation in children (excluding neonates)
1. Heart Rate; 2. Intubation, Intratracheal [adverse effects, *methods, statistics & numerical data]; 3. Laryngoscopy [adverse effects, *methods, statistics & numerical data]; 4. Oxygen [blood]; 5. Randomized Controlled Trials as Topic; 6. Time Factors; 7. Vocal Cords [diagnostic imaging];
MESH terms:
Morphine for chronic neuropathic pain in adults
1. Administration, Oral; 2. Analgesics, Opioid [*therapeutic use]; 3. Chronic Pain [*drug therapy]; 4. Morphine [*therapeutic use]; 5. Neuralgia [*drug therapy]; 6. Numbers Needed To Treat; 7. Randomized Controlled Trials as Topic; 8. Treatment Outcome;
MESH terms:
Methadone for neuropathic pain in adults
1. Analgesics, Opioid [adverse effects, *therapeutic use]; 2. Cross-Over Studies; 3. Methadone [adverse effects, *therapeutic use]; 4. Neuralgia [*drug therapy]; 5. Pain Measurement [statistics & numerical data]; 6. Patient Dropouts [statistics & numerical data]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Total intravenous anaesthesia versus inhalational anaesthesia for adults undergoing transabdominal robotic assisted laparoscopic surgery
1. *Anesthesia, Inhalation [adverse effects]; 2. *Anesthesia, Intravenous [adverse effects]; 3. Anesthetics, Inhalation [adverse effects]; 4. Anesthetics, Intravenous; 5. Intraocular Pressure [drug effects]; 6. Laparoscopy [*methods]; 7. Pain Measurement; 8. Pain, Postoperative [diagnosis, epidemiology]; 9. Postoperative Nausea and Vomiting [epidemiology, prevention & control]; 10. Propofol; 11. Prostatectomy [*methods]; 12. Randomized Controlled Trials as Topic; 13. Robotic Surgical Procedures [*methods];
MESH terms:
Oral nonsteroidal anti‐inflammatory drugs for fibromyalgia in adults
1. Administration, Oral; 2. Anti‐Inflammatory Agents, Non‐Steroidal [*administration & dosage, adverse effects]; 3. Fibromyalgia [*drug therapy]; 4. Pain Measurement [methods]; 5. Randomized Controlled Trials as Topic; 6. Withholding Treatment [statistics & numerical data];
MESH terms:
Topical anaesthetics for pain control during repair of dermal laceration
1. Anesthetics, Local [*administration & dosage, adverse effects, chemistry]; 2. Cocaine [administration & dosage, adverse effects]; 3. Drug Combinations; 4. Epinephrine [administration & dosage, adverse effects]; 5. Lacerations [*surgery]; 6. Pain Measurement; 7. Randomized Controlled Trials as Topic; 8. Skin [*injuries]; 9. Sutures; 10. Tetracaine [administration & dosage, adverse effects];
MESH terms:
Gabapentin for fibromyalgia pain in adults
1. Amines [adverse effects, *therapeutic use]; 2. Analgesics [adverse effects, *therapeutic use]; 3. Cyclohexanecarboxylic Acids [adverse effects, *therapeutic use]; 4. Fibromyalgia [*drug therapy]; 5. Gabapentin; 6. Randomized Controlled Trials as Topic; 7. gamma‐Aminobutyric Acid [adverse effects, *therapeutic use];
MESH terms:
Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults
1. Acetaminophen [*therapeutic use]; 2. Analgesics, Non‐Narcotic [*therapeutic use]; 3. Analgesics, Opioid [*therapeutic use]; 4. Chronic Pain [*drug therapy]; 5. Codeine [*analogs & derivatives, *therapeutic use]; 6. Neuralgia [*drug therapy];
MESH terms:
Intravenous nutrients for preventing inadvertent perioperative hypothermia in adults
1. *Body Temperature; 2. Administration, Intravenous; 3. Amino Acids [*administration & dosage]; 4. Fructose [*administration & dosage]; 5. Hypothermia [etiology, *prevention & control]; 6. Isotonic Solutions [administration & dosage]; 7. Randomized Controlled Trials as Topic; 8. Ringer's Lactate; 9. Shivering; 10. Sodium Chloride [administration & dosage]; 11. Time Factors;
MESH terms:
Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation
1. Acute Lung Injury [mortality, *therapy]; 2. Oxygen Consumption; 3. Positive‐Pressure Respiration, Intrinsic; 4. Pressure [adverse effects]; 5. Randomized Controlled Trials as Topic; 6. Respiration, Artificial [*methods]; 7. Respiratory Distress Syndrome [mortality, *therapy];
MESH terms:
Breastfeeding for procedural pain in infants beyond the neonatal period
1. Anesthetics, Local [administration & dosage]; 2. *Breast Feeding; 3. Crying [physiology]; 4. Glucose [administration & dosage]; 5. Heart Rate [physiology]; 6. Infant Care [methods]; 7. Lidocaine [administration & dosage]; 8. Lidocaine, Prilocaine Drug Combination; 9. Massage; 10. Pain [etiology, physiopathology, *prevention & control]; 11. Pain Management [methods]; 12. Pain Measurement [methods]; 13. Prilocaine [administration & dosage]; 14. Randomized Controlled Trials as Topic; 15. Time Factors; 16. Vaccination [*adverse effects];
MESH terms:
Anaesthetic interventions for prevention of awareness during surgery
1. *Anesthesia; 2. *Anesthetics; 3. Benzodiazepines [administration & dosage]; 4. Consciousness Monitors; 5. Electroencephalography [methods]; 6. Etomidate; 7. Intraoperative Awareness [*prevention & control]; 8. Ketamine; 9. Mental Recall; 10. Monitoring, Intraoperative [instrumentation, *methods]; 11. Randomized Controlled Trials as Topic; 12. Thiopental [administration & dosage]; 13. Wakefulness;
MESH terms:
Deliberate hypotension with propofol under anaesthesia for functional endoscopic sinus surgery (FESS)
1. *Anesthetics, Intravenous; 2. *Propofol; 3. Blood Loss, Surgical [*prevention & control]; 4. Endoscopy [*adverse effects, methods]; 5. Hypotension, Controlled [*methods]; 6. Operative Time; 7. Paranasal Sinuses [*surgery]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Fentanyl for neuropathic pain in adults
1. Analgesics, Opioid [*therapeutic use]; 2. Fentanyl [*therapeutic use]; 3. Neuralgia [*drug therapy]; 4. Pain Measurement; 5. Randomized Controlled Trials as Topic;
MESH terms:
Hyperbaric versus isobaric bupivacaine for spinal anaesthesia for caesarean section
1. *Cesarean Section; 2. Anesthesia, General; 3. Anesthesia, Obstetrical [*methods]; 4. Anesthesia, Spinal [*methods]; 5. Anesthetics, Local [*administration & dosage, chemistry]; 6. Bupivacaine [*administration & dosage, chemistry]; 7. Cerebrospinal Fluid; 8. Ephedrine [administration & dosage]; 9. Injections, Spinal; 10. Randomized Controlled Trials as Topic;
MESH terms:
Single, double or multiple‐injection techniques for non‐ultrasound guided axillary brachial plexus block in adults undergoing surgery of the lower arm
1. *Brachial Plexus; 2. Anesthetics, Local [*administration & dosage]; 3. Axilla [innervation]; 4. Elbow [surgery]; 5. Forearm [*surgery]; 6. Hand [*surgery]; 7. Intraoperative Complications [prevention & control]; 8. Nerve Block [*methods]; 9. Pain [prevention & control]; 10. Randomized Controlled Trials as Topic; 11. Tourniquets [adverse effects]; 12. Wrist [surgery];
MESH terms:
Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding
1. Blood Coagulation Disorders [*blood, diagnosis]; 2. Cardiac Surgical Procedures; 3. Erythrocyte Transfusion [*adverse effects, methods]; 4. Hemorrhage [blood, etiology, mortality, *therapy]; 5. Liver Transplantation; 6. Outcome Assessment, Health Care; 7. Plasma; 8. Randomized Controlled Trials as Topic; 9. Thrombelastography [adverse effects, *methods];
MESH terms:
Nitrous oxide‐based versus nitrous oxide‐free general anaesthesia and accidental awareness during general anaesthesia in surgical patients
1. *Anesthesia, General; 2. *Anesthetics, Inhalation; 3. *Intraoperative Awareness; 4. *Mental Recall; 5. *Nitrous Oxide; 6. *Surgical Procedures, Operative; 7. Randomized Controlled Trials as Topic;
MESH terms:
Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non‐cardiac surgery
1. Cause of Death; 2. Heart Diseases [complications, mortality, *prevention & control]; 3. Isosorbide Dinitrate [*therapeutic use]; 4. Morbidity; 5. Nicorandil [*therapeutic use]; 6. Nitroglycerin [*therapeutic use]; 7. Postoperative Complications [mortality, *prevention & control]; 8. Randomized Controlled Trials as Topic; 9. Surgical Procedures, Operative [*adverse effects]; 10. Vasodilator Agents [*therapeutic use];
MESH terms:
Local anaesthetic sympathetic blockade for complex regional pain syndrome
1. *Anesthetics, Local; 2. Autonomic Nerve Block [*methods]; 3. Causalgia [drug therapy]; 4. Complex Regional Pain Syndromes [*drug therapy]; 5. Randomized Controlled Trials as Topic; 6. Reflex Sympathetic Dystrophy [drug therapy];
MESH terms:
Oxycodone for neuropathic pain in adults
1. Analgesics, Opioid [adverse effects, *therapeutic use]; 2. Constipation [chemically induced, epidemiology]; 3. Delayed‐Action Preparations [therapeutic use]; 4. Diabetic Neuropathies [*drug therapy]; 5. Disorders of Excessive Somnolence [chemically induced, epidemiology]; 6. Dizziness [chemically induced, epidemiology]; 7. Nausea [chemically induced, epidemiology]; 8. Neuralgia, Postherpetic [drug therapy]; 9. Oxycodone [adverse effects, *therapeutic use]; 10. Randomized Controlled Trials as Topic;
MESH terms:
Percutaneous techniques versus surgical techniques for tracheostomy
1. Cicatrix [etiology]; 2. Critical Illness [*therapy]; 3. Dilatation [instrumentation, methods]; 4. Esophagus [injuries]; 5. Intraoperative Period; 6. Postoperative Hemorrhage [etiology]; 7. Randomized Controlled Trials as Topic; 8. Stomatitis [etiology]; 9. Surgical Wound Infection [etiology]; 10. Trachea [injuries, *surgery]; 11. Tracheostomy [adverse effects, *methods, mortality];
MESH terms:
High initial concentration versus low initial concentration sevoflurane for inhalational induction of anaesthesia
1. Anesthesia, Inhalation [adverse effects, *methods]; 2. Anesthetics, Inhalation [*administration & dosage, adverse effects]; 3. Methyl Ethers [*administration & dosage, adverse effects]; 4. Sevoflurane; 5. Time Factors;
MESH terms:
Paracetamol for low back pain
1. Acetaminophen [*therapeutic use]; 2. Analgesics, Non‐Narcotic [*therapeutic use]; 3. Low Back Pain [*drug therapy]; 4. Randomized Controlled Trials as Topic; 5. Treatment Outcome;
MESH terms:
Nutritional support for critically ill children
1. Burns [complications]; 2. Critical Illness [mortality, *therapy]; 3. Enteral Nutrition [*methods]; 4. Intensive Care Units, Pediatric; 5. Randomized Controlled Trials as Topic; 6. Time Factors;
MESH terms:
Psychological preparation and postoperative outcomes for adults undergoing surgery under general anaesthesia
1. *Affect; 2. Anesthesia, General; 3. Anxiety [therapy]; 4. Elective Surgical Procedures [*psychology]; 5. Length of Stay [*statistics & numerical data]; 6. Pain, Postoperative [*prevention & control]; 7. Patient Education as Topic [*methods]; 8. Preoperative Care [methods, *psychology]; 9. Randomized Controlled Trials as Topic; 10. Relaxation Therapy; 11. Sensation; 12. Thinking; 13. Treatment Outcome;
MESH terms:
Hydromorphone for neuropathic pain in adults
1. Analgesics, Opioid [*therapeutic use]; 2. Chronic Pain [*drug therapy]; 3. Hydromorphone [*therapeutic use]; 4. Neuralgia [*drug therapy]; 5. Randomized Controlled Trials as Topic;
MESH terms:
Midazolam for sedation before procedures
1. *Diagnostic Techniques and Procedures; 2. *Therapeutics; 3. Administration, Intranasal; 4. Administration, Oral; 5. Anxiety [*drug therapy]; 6. Chloral Hydrate [administration & dosage]; 7. Diazepam [administration & dosage]; 8. Hypnotics and Sedatives [*administration & dosage]; 9. Injections, Intravenous; 10. Midazolam [*administration & dosage]; 11. Randomized Controlled Trials as Topic;
MESH terms:
Lateral positioning for critically ill adult patients
1. *Critical Illness; 2. *Posture; 3. Hypoxia [diagnosis]; 4. Lung Diseases [physiopathology]; 5. Oxygen [blood]; 6. Partial Pressure; 7. Patient Positioning [adverse effects, *methods]; 8. Randomized Controlled Trials as Topic; 9. Respiratory Distress Syndrome [physiopathology]; 10. Uncertainty;
MESH terms:
Topical NSAIDs for chronic musculoskeletal pain in adults
1. Administration, Topical; 2. Anti‐Inflammatory Agents, Non‐Steroidal [*administration & dosage, adverse effects]; 3. Chronic Pain [*drug therapy]; 4. Diclofenac [*administration & dosage, adverse effects]; 5. Ketoprofen [*administration & dosage, adverse effects]; 6. Musculoskeletal Pain [*drug therapy]; 7. Numbers Needed To Treat; 8. Randomized Controlled Trials as Topic;
MESH terms:
Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults
1. Air; 2. Blood Loss, Surgical; 3. Body Surface Area; 4. Body Temperature Regulation; 5. Cardiovascular Diseases [prevention & control]; 6. Cold Temperature [adverse effects]; 7. Heating [instrumentation, *methods]; 8. Hypothermia [etiology, *prevention & control]; 9. Intraoperative Complications [*prevention & control]; 10. Randomized Controlled Trials as Topic; 11. Surgical Wound Infection [prevention & control];
MESH terms:
Catheter impregnation, coating or bonding for reducing central venous catheter‐related infections in adults
1. Anti‐Infective Agents [*administration & dosage]; 2. Catheter‐Related Infections [*prevention & control]; 3. Central Venous Catheters [*adverse effects]; 4. Randomized Controlled Trials as Topic;
MESH terms:
Spectral entropy monitoring for adults and children undergoing general anaesthesia
1. *Anesthesia, General [mortality]; 2. *Entropy; 3. Anesthesia Recovery Period; 4. Anesthetics [administration & dosage]; 5. Intraoperative Awareness [prevention & control]; 6. Isoflurane [administration & dosage]; 7. Memory, Short‐Term; 8. Methyl Ethers [administration & dosage]; 9. Propofol [administration & dosage]; 10. Randomized Controlled Trials as Topic; 11. Sevoflurane; 12. Time Factors;
MESH terms:
Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
1. Acute Pain [prevention & control]; 2. Anesthesia, Epidural [adverse effects, *methods, mortality]; 3. Delirium [etiology]; 4. Hypotension [etiology]; 5. Length of Stay; 6. Lung Diseases [etiology]; 7. Nerve Block [adverse effects, *methods, mortality]; 8. Pain, Postoperative [*prevention & control]; 9. Randomized Controlled Trials as Topic; 10. Thoracotomy [*adverse effects, mortality];
MESH terms:
Lidocaine for reducing propofol‐induced pain on induction of anaesthesia in adults
1. Anesthesia; 2. Anesthesiology; 3. Anesthetics, Intravenous [administration & dosage, *adverse effects]; 4. Anesthetics, Local [*administration & dosage]; 5. Lidocaine [*administration & dosage]; 6. Pain [chemically induced, *prevention & control]; 7. Propofol [administration & dosage, *adverse effects];
MESH terms:
Vasopressors for hypotensive shock
1. Drug Therapy, Combination; 2. Hypotension [*drug therapy, mortality]; 3. Randomized Controlled Trials as Topic; 4. Shock [*drug therapy, mortality]; 5. Shock, Septic [drug therapy, mortality]; 6. Vasoconstrictor Agents [adverse effects, *therapeutic use];
MESH terms:
Pharmacological and non‐pharmacological interventions for reducing rocuronium bromide induced pain on injection in children and adults
1. Acetaminophen [therapeutic use]; 2. Analgesics, Opioid [therapeutic use]; 3. Androstanols [administration & dosage, *adverse effects]; 4. Anesthetics, Local [therapeutic use]; 5. Fentanyl [therapeutic use]; 6. Lidocaine [therapeutic use]; 7. Neuromuscular Depolarizing Agents [administration & dosage, *adverse effects]; 8. Pain [etiology, *prevention & control]; 9. Pain Measurement; 10. Piperidines [therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Remifentanil; 13. Rocuronium;
MESH terms:
Intranasal or transdermal nicotine for the treatment of postoperative pain
1. Administration, Cutaneous; 2. Administration, Intranasal; 3. Analgesics, Opioid [adverse effects, *therapeutic use]; 4. Nicotine [*administration & dosage, adverse effects]; 5. Pain, Postoperative [*drug therapy]; 6. Postoperative Nausea and Vomiting [chemically induced]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Epidural pain relief versus systemic opioid‐based pain relief for abdominal aortic surgery
1. Analgesia, Epidural [adverse effects, *methods]; 2. Analgesics, Opioid [adverse effects, *therapeutic use]; 3. Aorta, Abdominal [*surgery]; 4. Cause of Death; 5. Intubation, Intratracheal [statistics & numerical data]; 6. Myocardial Infarction [prevention & control]; 7. Pain Management [methods]; 8. Pain Measurement; 9. Pain, Postoperative [*prevention & control]; 10. Postoperative Complications [mortality]; 11. Randomized Controlled Trials as Topic; 12. Respiration, Artificial [statistics & numerical data]; 13. Time Factors;
MESH terms:
Effectiveness and risks of cricoid pressure during rapid sequence induction for endotracheal intubation
1. *Cricoid Cartilage; 2. Intubation, Intratracheal [*methods]; 3. Pneumonia, Aspiration [prevention & control]; 4. Pressure [*adverse effects]; 5. Randomized Controlled Trials as Topic;
MESH terms:
Prone position for acute respiratory failure in adults
1. Acute Disease; 2. Hypoxia [etiology, mortality, therapy]; 3. Patient Positioning [*methods, mortality]; 4. *Prone Position; 5. Randomized Controlled Trials as Topic; 6. Respiration, Artificial [*methods, mortality]; 7. Respiratory Distress Syndrome [mortality, *therapy]; 8. Respiratory Insufficiency [mortality, *therapy];
MESH terms:
Nitrous oxide‐based techniques versus nitrous oxide‐free techniques for general anaesthesia
1. Anesthesia, General [*adverse effects, methods]; 2. Anesthetics, Inhalation [*adverse effects]; 3. Myocardial Infarction [etiology]; 4. Nausea [etiology]; 5. Nitrous Oxide [*adverse effects]; 6. Pneumonia [etiology]; 7. Pulmonary Atelectasis [etiology]; 8. Randomized Controlled Trials as Topic; 9. Stroke [etiology]; 10. Surgical Wound Infection [etiology]; 11. Venous Thromboembolism [etiology]; 12. Vomiting [etiology];
MESH terms:
Rocuronium versus succinylcholine for rapid sequence induction intubation
1. Androstanols [*administration & dosage]; 2. Intubation, Intratracheal [*methods]; 3. Neuromuscular Depolarizing Agents [*administration & dosage, adverse effects]; 4. Neuromuscular Nondepolarizing Agents [*administration & dosage, adverse effects]; 5. Propofol [administration & dosage]; 6. Randomized Controlled Trials as Topic; 7. Rocuronium; 8. Succinylcholine [*administration & dosage, adverse effects];
MESH terms:
Non‐pharmacological interventions for sleep promotion in the intensive care unit
1. Delirium [*prevention & control]; 2. Ear Protective Devices; 3. Eye Protective Devices; 4. *Intensive Care Units; 5. Length of Stay; 6. Music; 7. Randomized Controlled Trials as Topic; 8. *Sleep; 9. Sleep Wake Disorders [*therapy]; 10. Ventilators, Mechanical;
MESH terms:
Ultrasound guidance for upper and lower limb blocks
1. Arm; 2. Leg; 3. Nerve Block [adverse effects, *methods]; 4. Peripheral Nerves [*diagnostic imaging]; 5. Randomized Controlled Trials as Topic; 6. Transcutaneous Electric Nerve Stimulation; 7. Ultrasonography, Interventional [*methods];
MESH terms:
Regional analgesia for improvement of long‐term functional outcome after elective large joint replacement
1. Analgesia [*methods]; 2. Anesthesia, Conduction [*methods]; 3. Arthroplasty, Replacement, Knee [*rehabilitation]; 4. Knee Joint [physiology]; 5. Pain, Postoperative [*drug therapy]; 6. Randomized Controlled Trials as Topic; 7. Range of Motion, Articular; 8. Time Factors;
MESH terms:
Alpha‐2 adrenergic agonists for the prevention of shivering following general anaesthesia
1. Adrenergic alpha‐Agonists [adverse effects, *therapeutic use]; 2. Anesthesia, General [*adverse effects]; 3. Clonidine [adverse effects, *therapeutic use]; 4. Dexmedetomidine [adverse effects, *therapeutic use]; 5. Hypothermia; 6. Randomized Controlled Trials as Topic; 7. Shivering [*drug effects];
MESH terms:
Early versus late removal of the laryngeal mask airway (LMA) for general anaesthesia
1. Airway Obstruction [etiology]; 2. Anesthesia Recovery Period; 3. *Anesthesia, General; 4. Cough [etiology]; 5. *Device Removal [adverse effects]; 6. *Laryngeal Masks; 7. Laryngismus [etiology]; 8. Oxygen [blood]; 9. Randomized Controlled Trials as Topic; 10. Time Factors;
MESH terms:
The use of propofol for procedural sedation in emergency departments
1. *Anesthesia; 2. *Anesthetics, Intravenous [administration & dosage, adverse effects]; 3. *Emergency Service, Hospital; 4. *Propofol [administration & dosage, adverse effects]; 5. Etomidate [administration & dosage]; 6. Fentanyl [administration & dosage]; 7. Ketamine [administration & dosage, adverse effects]; 8. Midazolam [administration & dosage]; 9. Randomized Controlled Trials as Topic;
MESH terms:
Lidocaine for preventing postoperative sore throat
1. Anesthesia, General [adverse effects]; 2. Anesthetics, Local [adverse effects, *therapeutic use]; 3. Intubation, Intratracheal [adverse effects]; 4. Lidocaine [adverse effects, *therapeutic use]; 5. Pharyngitis [etiology, *prevention & control]; 6. Postoperative Complications [*prevention & control]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Non‐pharmacological interventions for assisting the induction of anaesthesia in children
1. Acupuncture Therapy; 2. Anesthesia, General [*psychology]; 3. Anxiety [*prevention & control]; 4. *Cooperative Behavior; 5. Hypnosis, Anesthetic [psychology]; 6. Music Therapy; 7. Noise [prevention & control]; 8. Parents [psychology]; 9. Physician's Role [psychology]; 10. Preanesthetic Medication; 11. Randomized Controlled Trials as Topic; 12. Stress, Psychological [*prevention & control]; 13. Video Games [psychology];
MESH terms:
Peribulbar versus retrobulbar anaesthesia for cataract surgery
1. Anesthesia, Local [adverse effects, *methods]; 2. Cataract Extraction [*methods]; 3. Nerve Block [adverse effects, *methods]; 4. Pain Measurement; 5. Randomized Controlled Trials as Topic;
MESH terms:
The effects of high perioperative inspiratory oxygen fraction for adult surgical patients
1. Anesthesia; 2. Cause of Death; 3. Length of Stay; 4. Oxygen [*administration & dosage, *adverse effects]; 5. Oxygen Inhalation Therapy [*adverse effects, methods, mortality]; 6. Randomized Controlled Trials as Topic; 7. Respiratory Insufficiency [*etiology]; 8. Selection Bias; 9. Surgical Procedures, Operative [*mortality]; 10. Surgical Wound Infection [*etiology];
MESH terms:
Exercise rehabilitation following intensive care unit discharge for recovery from critical illness
1. *Critical Care; 2. *Exercise Therapy; 3. Controlled Clinical Trials as Topic; 4. Critical Illness [*rehabilitation]; 5. Health Status; 6. Intensive Care Units; 7. Length of Stay; 8. Muscle Weakness [etiology, *rehabilitation]; 9. Muscular Disorders, Atrophic [etiology, *rehabilitation]; 10. Patient Discharge; 11. Quality of Life; 12. Randomized Controlled Trials as Topic; 13. Respiration, Artificial; 14. Selection Bias;
MESH terms:
Tapentadol for chronic musculoskeletal pain in adults
1. Analgesics, Opioid [*therapeutic use]; 2. Chronic Pain [*drug therapy]; 3. Clinical Trials, Phase III as Topic; 4. Low Back Pain [*drug therapy]; 5. Musculoskeletal Pain [*drug therapy]; 6. Osteoarthritis, Knee [*drug therapy]; 7. Oxycodone [therapeutic use]; 8. Phenols [*therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Tapentadol;
MESH terms:
Warming of intravenous and irrigation fluids for preventing inadvertent perioperative hypothermia
1. *Body Temperature; 2. Administration, Intravenous; 3. Anesthesia [adverse effects]; 4. Hot Temperature; 5. Hypothermia [etiology, *prevention & control]; 6. Infusions, Intravenous [*methods]; 7. Randomized Controlled Trials as Topic; 8. Shivering; 9. Therapeutic Irrigation [*methods];
MESH terms:
Adrenaline with lidocaine for digital nerve blocks
1. *Anesthetics, Local; 2. Emergencies; 3. *Epinephrine; 4. Finger Injuries [*surgery]; 5. Fingers [*surgery]; 6. *Lidocaine; 7. Nerve Block [*methods]; 8. Randomized Controlled Trials as Topic; 9. Toes [*injuries, *surgery];
MESH terms:
Zonisamide for neuropathic pain in adults
1. Analgesics [*therapeutic use]; 2. Anticonvulsants [therapeutic use]; 3. Diabetic Neuropathies [*drug therapy]; 4. Isoxazoles [*therapeutic use]; 5. Neuralgia [*drug therapy]; 6. Zonisamide;
MESH terms:
Ultrasound guidance versus anatomical landmarks for internal jugular vein catheterization
1. *Anatomic Landmarks; 2. *Jugular Veins; 3. Catheterization, Central Venous [adverse effects, *methods, statistics & numerical data]; 4. Punctures [adverse effects, *methods, statistics & numerical data]; 5. Randomized Controlled Trials as Topic; 6. Ultrasonography, Interventional [*methods];
MESH terms:
Ultrasound guidance versus anatomical landmarks for subclavian or femoral vein catheterization
1. *Femoral Vein; 2. *Subclavian Vein; 3. *Ultrasonography, Interventional; 4. Anatomic Landmarks [*anatomy & histology]; 5. Catheterization, Central Venous [*methods]; 6. Critical Illness; 7. Punctures [*methods]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Nortriptyline for neuropathic pain in adults
1. Amines [therapeutic use]; 2. Amitriptyline [therapeutic use]; 3. Analgesics [*therapeutic use]; 4. Antidepressive Agents, Tricyclic [therapeutic use]; 5. Clomipramine [therapeutic use]; 6. Cyclohexanecarboxylic Acids [therapeutic use]; 7. Gabapentin; 8. Morphine [therapeutic use]; 9. Neuralgia [*drug therapy]; 10. Nortriptyline [*therapeutic use]; 11. Pregabalin [therapeutic use]; 12. Randomized Controlled Trials as Topic; 13. gamma‐Aminobutyric Acid [therapeutic use];
MESH terms:
Conservative versus interventional management for primary spontaneous pneumothorax in adults
1. Pneumothorax [*therapy];
MESH terms:
Intranasal fentanyl for the management of acute pain in children
1. Acute Pain [*drug therapy]; 2. Administration, Intranasal; 3. Analgesics, Opioid [*administration & dosage]; 4. Fentanyl [*administration & dosage]; 5. Morphine [administration & dosage]; 6. Pain Measurement; 7. Randomized Controlled Trials as Topic;
MESH terms:
Desipramine for neuropathic pain in adults
1. Amitriptyline [therapeutic use]; 2. Analgesics [*therapeutic use]; 3. Antidepressive Agents, Tricyclic [*therapeutic use]; 4. Chronic Pain [*drug therapy]; 5. Clomipramine [therapeutic use]; 6. Desipramine [*therapeutic use]; 7. Diabetic Neuropathies [*drug therapy]; 8. Fluoxetine [therapeutic use]; 9. Neuralgia, Postherpetic [*drug therapy]; 10. Randomized Controlled Trials as Topic;
MESH terms:
Effects of sevoflurane versus other general anaesthesia on emergence agitation in children
1. *Anesthesia Recovery Period; 2. Adjuvants, Anesthesia [*adverse effects]; 3. Akathisia, Drug‐Induced [etiology, *prevention & control]; 4. Anesthesia, General; 5. Anesthetics, Inhalation [*adverse effects]; 6. Clonidine [adverse effects]; 7. Desflurane; 8. Dexmedetomidine [adverse effects]; 9. Halothane [adverse effects]; 10. Isoflurane [adverse effects, analogs & derivatives]; 11. Methyl Ethers [*adverse effects]; 12. Midazolam [adverse effects]; 13. Propofol [adverse effects]; 14. Sevoflurane;
MESH terms:
Botulinum toxin for myofascial pain syndromes in adults
1. Botulinum Toxins, Type A [*therapeutic use]; 2. Myofascial Pain Syndromes [*drug therapy]; 3. Neuromuscular Agents [*therapeutic use]; 4. Pain Measurement [methods]; 5. Pain, Referred [*drug therapy]; 6. Randomized Controlled Trials as Topic; 7. Trigger Points;
MESH terms:
Topical lidocaine for neuropathic pain in adults
1. Anesthetics, Local [*administration & dosage]; 2. Lidocaine [*administration & dosage]; 3. Neuralgia [*drug therapy, etiology]; 4. Neuralgia, Postherpetic [*drug therapy]; 5. Pain, Postoperative [*drug therapy]; 6. Randomized Controlled Trials as Topic; 7. Trigeminal Neuralgia [*drug therapy];
MESH terms:
Air versus saline in the loss of resistance technique for identification of the epidural space
1. *Air; 2. *Sodium Chloride [administration & dosage]; 3. Anesthesia, Epidural [instrumentation, *methods]; 4. Catheterization [adverse effects, instrumentation]; 5. Elasticity [physiology]; 6. Epidural Space [*anatomy & histology]; 7. Ligamentum Flavum [physiology]; 8. Medical Errors [statistics & numerical data]; 9. Paresthesia [etiology]; 10. Post‐Dural Puncture Headache [etiology]; 11. Pressure; 12. Randomized Controlled Trials as Topic;
MESH terms:
Mannitol versus hypertonic saline for brain relaxation in patients undergoing craniotomy
1. Brain Neoplasms [complications, *surgery]; 2. Craniotomy [*methods]; 3. Encephalitis [etiology, *therapy]; 4. Glasgow Outcome Scale; 5. Hypertonic Solutions [adverse effects, *therapeutic use]; 6. Mannitol [adverse effects, *therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Saline Solution, Hypertonic [adverse effects, *therapeutic use];
MESH terms:
Physician anaesthetists versus non‐physician providers of anaesthesia for surgical patients
1. *Anesthesiology; 2. *Nurse Anesthetists; 3. *Physician Assistants; 4. Anesthesia [adverse effects, mortality]; 5. Anesthesia, Obstetrical [mortality]; 6. Anesthetics [*administration & dosage, adverse effects]; 7. Cesarean Section [mortality]; 8. Cohort Studies; 9. Observational Studies as Topic; 10. Retrospective Studies; 11. Surgical Procedures, Operative [*statistics & numerical data];
MESH terms:
Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation
1. *Critical Illness; 2. Analgesics [*administration & dosage]; 3. Drug Administration Schedule; 4. Hospital Mortality; 5. Hypnotics and Sedatives [*administration & dosage, adverse effects, metabolism]; 6. Intensive Care Units [statistics & numerical data]; 7. Length of Stay [statistics & numerical data]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Respiration, Artificial [mortality, *statistics & numerical data]; 11. Time Factors; 12. Tracheostomy [statistics & numerical data];
MESH terms:
Levetiracetam for neuropathic pain in adults
1. Analgesics [*therapeutic use]; 2. Chronic Disease; 3. Levetiracetam; 4. Neuralgia [classification, *drug therapy, etiology]; 5. Piracetam [*analogs & derivatives, therapeutic use]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
1. Administration, Inhalation; 2. Heart Defects, Congenital [*surgery]; 3. Heart Diseases [congenital, surgery]; 4. Hypertension, Pulmonary [*drug therapy, mortality]; 5. Nitric Oxide [administration & dosage, *therapeutic use]; 6. Postoperative Complications [*drug therapy, mortality]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Automated versus non‐automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children
1. *Critical Illness; 2. Intensive Care Units; 3. Length of Stay; 4. Randomized Controlled Trials as Topic; 5. Respiration, Artificial [*methods, statistics & numerical data]; 6. Time Factors; 7. Ventilator Weaning [*methods, statistics & numerical data];
MESH terms:
Pressure support versus T‐tube for weaning from mechanical ventilation in adults
1. Pressure; 2. Randomized Controlled Trials as Topic; 3. Respiration, Artificial [instrumentation, *methods]; 4. Respiratory Insufficiency [*therapy]; 5. Tracheostomy [*instrumentation]; 6. Ventilator Weaning [instrumentation, *methods];
MESH terms:
Imipramine for neuropathic pain in adults
1. Analgesics [*therapeutic use]; 2. Antidepressive Agents, Tricyclic [*therapeutic use]; 3. Diabetic Neuropathies [*drug therapy]; 4. Imipramine [*therapeutic use]; 5. Neuralgia [*drug therapy]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Heparin versus normal saline for patency of arterial lines
1. *Catheter Obstruction; 2. Anticoagulants [*administration & dosage]; 3. Heparin [*administration & dosage]; 4. Randomized Controlled Trials as Topic; 5. Sodium Chloride [*administration & dosage];
MESH terms:
Permissive hypoxaemia versus normoxaemia for mechanically ventilated critically ill patients
1. *Critical Illness; 2. *Hypoxia; 3. *Respiration, Artificial; 4. Oxygen [*blood]; 5. Reference Values;
MESH terms:
Neostigmine for reversal of neuromuscular block in paediatric patients
1. *Neuromuscular Blockade; 2. Neostigmine [adverse effects, *therapeutic use]; 3. Neuromuscular Nondepolarizing Agents [adverse effects, *therapeutic use];
MESH terms:
High‐flow nasal cannula therapy for respiratory support in children
1. Masks; 2. Oxygen Inhalation Therapy [*methods]; 3. Respiration, Artificial [*methods];
MESH terms:
Automated weaning and spontaneous breathing trial systems versus non‐automated weaning strategies for discontinuation time in invasively ventilated postoperative adults
1. *Respiration; 2. Postoperative Care [methods]; 3. Randomized Controlled Trials as Topic; 4. Time Factors; 5. Ventilator Weaning [*methods];
MESH terms:
Incentive spirometry for prevention of postoperative pulmonary complications in upper abdominal surgery
1. Abdomen [*surgery]; 2. Bronchial Diseases [prevention & control]; 3. Lung Diseases [*prevention & control]; 4. Pneumonia [prevention & control]; 5. Postoperative Complications [*prevention & control]; 6. Pulmonary Atelectasis [prevention & control]; 7. Randomized Controlled Trials as Topic; 8. Respiratory Insufficiency [prevention & control]; 9. Respiratory Therapy [methods]; 10. Spirometry [*methods]; 11. Tracheal Diseases [prevention & control];
MESH terms:
Intravenous versus inhalational anaesthesia for paediatric outpatient surgery
1. *Ambulatory Surgical Procedures; 2. Anesthesia, Inhalation [adverse effects, *methods]; 3. Anesthesia, Intravenous [adverse effects, *methods]; 4. Anesthetics, Inhalation [adverse effects]; 5. Anesthetics, Intravenous [adverse effects]; 6. Hospitalization; 7. Methyl Ethers [adverse effects]; 8. Postoperative Nausea and Vomiting [chemically induced]; 9. Propofol [adverse effects]; 10. Randomized Controlled Trials as Topic; 11. Sevoflurane;
MESH terms:
Continuous interscalene brachial plexus block versus parenteral analgesia for postoperative pain relief after major shoulder surgery
1. *Brachial Plexus; 2. Analgesics, Opioid [*administration & dosage]; 3. Anesthesia, Local [*methods]; 4. Nerve Block [*methods]; 5. Pain, Postoperative [*therapy]; 6. Pirinitramide [administration & dosage]; 7. Randomized Controlled Trials as Topic; 8. Shoulder [*surgery]; 9. Sufentanil [administration & dosage];
MESH terms:
Fibrinogen concentrate in bleeding patients
1. Blood Transfusion [statistics & numerical data]; 2. Cardiac Surgical Procedures; 3. Elective Surgical Procedures; 4. Fibrinogen [*therapeutic use]; 5. Hemorrhage [mortality, *therapy]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Opioids for neuropathic pain
1. Analgesics, Opioid [adverse effects, *therapeutic use]; 2. Nervous System Diseases [complications, *drug therapy]; 3. Neuralgia [*drug therapy]; 4. Pain [*drug therapy, etiology]; 5. Pain Measurement [methods, statistics & numerical data]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Protocolized versus non‐protocolized weaning for reducing the duration of invasive mechanical ventilation in critically ill paediatric patients
1. *Critical Illness; 2. Clinical Protocols; 3. Intensive Care Units, Pediatric; 4. Randomized Controlled Trials as Topic; 5. Respiration, Artificial; 6. Time Factors; 7. Ventilator Weaning [adverse effects, *methods];
MESH terms:
Neuraxial anaesthesia for lower‐limb revascularization
1. Amputation, Surgical [statistics & numerical data]; 2. Anesthesia, Epidural [*adverse effects, mortality]; 3. Anesthesia, General [*adverse effects, mortality]; 4. Anesthesia, Spinal [*adverse effects, mortality]; 5. Lower Extremity [*blood supply, surgery]; 6. Myocardial Infarction [epidemiology]; 7. Pneumonia [epidemiology]; 8. Randomized Controlled Trials as Topic; 9. Vascular Surgical Procedures;
MESH terms:
Pharmacotherapy for the prevention of chronic pain after surgery in adults
1. Adrenal Cortex Hormones [therapeutic use]; 2. Amines [therapeutic use]; 3. Analgesics [*therapeutic use]; 4. Chronic Pain [*prevention & control]; 5. Cyclohexanecarboxylic Acids [therapeutic use]; 6. Gabapentin; 7. gamma-Aminobutyric Acid [analogs & derivatives, therapeutic use]; 8. Ibuprofen [therapeutic use]; 9. Ketamine [therapeutic use]; 10. Mexiletine [therapeutic use]; 11. Pain, Postoperative [*prevention & control]; 12. Pregabalin; 13. Randomized Controlled Trials as Topic;
MESH terms:
Intravenous versus inhalation anaesthesia for one‐lung ventilation
1. *Anesthesia, Inhalation; 2. *Anesthesia, Intravenous; 3. One‐Lung Ventilation [*methods]; 4. Randomized Controlled Trials as Topic; 5. Treatment Outcome;
MESH terms:
Single dose oral ibuprofen plus oxycodone for acute postoperative pain in adults
1. Acute Pain [*drug therapy]; 2. Administration, Oral; 3. Analgesics, Non‐Narcotic [*administration & dosage, adverse effects]; 4. Analgesics, Opioid [*administration & dosage, adverse effects]; 5. Drug Combinations; 6. Ibuprofen [*administration & dosage, adverse effects]; 7. Oxycodone [*administration & dosage, adverse effects]; 8. Pain, Postoperative [*drug therapy]; 9. Randomized Controlled Trials as Topic;
MESH terms:
Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain
1. Acetaminophen [*administration & dosage, adverse effects]; 2. Acute Pain [*drug therapy]; 3. Administration, Oral; 4. Analgesics, Non‐Narcotic [*administration & dosage, adverse effects]; 5. Drug Combinations; 6. Ibuprofen [*administration & dosage, adverse effects]; 7. Pain, Postoperative [*drug therapy]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care units
1. *Critical Illness; 2. *Metered Dose Inhalers; 3. *Nebulizers and Vaporizers; 4. *Respiration, Artificial; 5. Aerosols; 6. Airway Resistance [*drug effects, physiology]; 7. Bronchodilator Agents [*administration & dosage]; 8. Heart Rate [drug effects, physiology]; 9. Intensive Care Units; 10. Randomized Controlled Trials as Topic;
MESH terms:
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus
1. *Bias; 2. *Cerebral Palsy [prevention & control]; 3. *Magnesium Sulfate [adverse effects, therapeutic use]; 4. *Neuroprotective Agents [therapeutic use]; 5. *Premature Birth [prevention & control]; 6. *Randomized Controlled Trials as Topic; 7. Tocolytic Agents [therapeutic use];
MESH terms:
Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia
1. *Eclampsia [drug therapy]; 2. Magnesium Sulfate [adverse effects]; 3. *Maternal Death; 4. *Perinatal Death; 5. *Pre-Eclampsia [drug therapy, prevention & control]; 6. Seizures; 7. Stillbirth;
MESH terms:
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy
1. Fetal Death; 2. *Fetal Growth Retardation [drug therapy]; 3. Nitric Oxide [therapeutic use]; 4. Nitroglycerin; 5. Placenta; 6. *Premature Birth [prevention & control]; 7. Sildenafil Citrate; 8. Tadalafil;
MESH terms:
Planned hospital birth compared with planned home birth for pregnant women at low risk of complications
1. *Home Childbirth [adverse effects]; 2. Hospitals; 3. Parturition; 4. *Perinatal Death; 5. Pregnant Women; 6. Systematic Reviews as Topic;
MESH terms:
Induction of labour at or near term for suspected fetal macrosomia
1. Birth Weight; 2. *Cesarean Section; 3. Fetal Macrosomia; 4. Fetal Weight; 5. Labor, Induced [methods]; 6. *Shoulder Dystocia;
MESH terms:
Cervical pessary for preventing preterm birth in singleton pregnancies
1. *Cerclage, Cervical; 2. Cervix Uteri; 3. Pessaries [adverse effects]; 4. *Premature Birth [prevention & control]; 5. Progesterone;
MESH terms:
Maternal postures for fetal malposition in labour for improving the health of mothers and their infants
1. *Brain Diseases; 2. *Jaundice, Neonatal; 3. Mothers; 4. *Postpartum Hemorrhage; 5. Posture; 6. Stillbirth;
MESH terms:
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth
1. Adrenal Cortex Hormones; 2. Betamethasone [adverse effects]; 3. *Chorioamnionitis; 4. Dexamethasone [adverse effects]; 5. Infant, Premature; 6. Lung; 7. *Premature Birth [epidemiology, prevention & control]; 8. *Respiratory Distress Syndrome, Newborn [prevention & control];
MESH terms:
Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes
1. *Adrenal Cortex Hormones [therapeutic use]; 2. Odds Ratio; 3. Outcome Assessment, Health Care; 4. *Premature Birth [prevention & control]; 5. Vitamins;
MESH terms:
Routine vaginal examinations compared to other methods for assessing progress of labour to improve outcomes for women and babies at term
1. *Chorioamnionitis; 2. *Dystocia [diagnosis]; 3. Gynecological Examination; 4. *Labor, Obstetric [physiology]; 5. Pain;
MESH terms:
Interventions for fear of childbirth including tocophobia
1. Analgesia, Epidural [psychology, statistics & numerical data]; 2. Analgesia, Obstetrical [psychology, statistics & numerical data]; 3. Art Therapy; 4. Bias; 5. Cesarean Section [psychology, statistics & numerical data]; 6. Cognitive Behavioral Therapy; 7. Counseling; 8. Depression [epidemiology]; 9. Fear [*psychology]; 10. Midwifery; 11. Parturition [*psychology]; 12. Phobic Disorders [*therapy]; 13. Randomized Controlled Trials as Topic;
MESH terms:
Low‐dose oral misoprostol for induction of labour
1. Administration, Intravaginal; 2. Administration, Oral; 3. Apgar Score; 4. Cesarean Section [statistics & numerical data]; 5. Dinoprostone [administration & dosage]; 6. Drug Administration Schedule; 7. Heart Rate, Fetal [drug effects]; 8. Intensive Care, Neonatal [statistics & numerical data]; 9. Labor, Induced [*methods]; 10. Misoprostol [*administration & dosage]; 11. Oxytocics [*administration & dosage]; 12. Oxytocin [administration & dosage]; 13. Parturition; 14. Placebos [administration & dosage]; 15. Randomized Controlled Trials as Topic; 16. Time Factors; 17. Uterus [drug effects];